New Delhi: The National Pharmaceutical Pricing Authority (NPPA), India’s drug-price regulator, has approved a price increase of over 50 per cent for essential drugs used to treat medical conditions like asthma, glaucoma, thalassemia, tuberculosis, and mental health issues. According to the Ministry of Health and Family Welfare, the decision was made on October 8, during a full Authority meeting, utilising the extraordinary powers granted under Para 19 of the Drugs (Prices Control) Order, 2013.
Why Were The Prices Revised?The NPPA revised the ceiling prices of eight scheduled drugs to meet the “twin objectives of availability and affordability”, the authority claimed in a press release. “Most of these drugs are low-cost and generally used as first-line treatment crucial to the public health programmes of the country.”Eleven formulations for which ceiling prices have been revised include benzylpenicillin (10 lakh IU injection), atropine injection (0.6 mg per ml), streptomycin powder (for injection 750 mg and 1000 mg), salbutamol tablet (2 mg and 4 mg), respirator solution (5 mg per ml), Pilocarpine 2% drops, Cefadroxil tablet (500 mg), Desferrioxamine (500 mg for injection) and Lithium tablets (300 mg).These medications are often used as first-line treatments in public health programs, and the price adjustments aim to prevent shortages or market withdrawal due to production challenges. How Much The Medicines Will Cost Now?The cost of these medicines will range Rs 1.02 per ml solution to Rs 16.25 per ml drop, with the exception of a more expensive Desferroxamine that will cost a little over Rs 280 per vial.Notably, the medicines for which the prices have been increased are not very expensive to begin with. So the 50 per cent increase in ceiling prices is unlikely to hit people very hard. Similar measures were taken in 2019 and 2021, when ceiling prices for 21 and 9 formulations, respectively, were increased by 50 per cent. These interventions highlight the NPPA's ongoing efforts to strike a balance between maintaining drug affordability and ensuring their availability, particularly for treatments that are crucial to the nation's healthcare system.You may also like
Amanda Abbington reveals next role and surprise dream to star in much-loved soap
Rohit Sharma Eyes Expanded Bench Strength In Fast-bowling Department
Pub on tiny remote island that can only be visited by 12 people at a time
Drink to Your Health: The Incredible Benefits of Pomegranate Juice
Loose Women star Linda Robson shares devastating baby loss live on ITV
PM Modi Calls for Global Collaboration to Combat Cyber Crimes
'I divorced my husband to save our relationship – now we're happily dating'
India doesn't see immediate impact on trade ties with Canada: Report
2nd Open Talent Hunt: Haryana boxers win bulk of medals in Elite and Youth categories
Two Indians arrested for smuggling drugs in Nepal
BBC Death In Paradise announces new project with fan favourites
Indian Navy is biggest guarantee of peace in Indian Ocean Region, says Rajnath Singh
CSIR NET Result 2024: Joint CSIR NET Result June Released at csirnet.nta.ac.in, Direct Link
Rashmika Mandanna Named National Brand Ambassador Of Indian Cyber Crime Coordination Centre
Olympian Manu Bhaker fires back at her trolls, says "no one needs to tell me what my goals are"
'It will help understanding of civilisational history': PM Modi lauds national maritime heritage complex in Gujarat's Lothal
Fertiglobe becomes Adnoc's platform for low-carbon ammonia growth globally
Major airline threatens to axe routes to popular Christmas weekend break hotspot
JD-U to contest 11 seats in Jharkhand
Doctor issues stark 'tripledemic' warning that could put huge strain on NHS